ImClone Investigational Site

Providence, Rhode Island 02903

0 studies enrolling now · 3 studies all time

What they study most

Adenocarcinoma, Cancer, Carcinoma, Gastric Cancer, Neuroendocrine Tumors, Solid Tumor

Studies at this site

• Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma — Completed
• A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer — Completed
• Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes — Completed